Article info

Download PDFPDF

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis

Authors

  • Francesca Poggio Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, Genova, Italy PubMed articlesGoogle scholar articles
  • Marco Bruzzone Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy PubMed articlesGoogle scholar articles
  • Marcello Ceppi Unit of Clinical Epidemiology, Ospedale Policlinico San Martino, Genova, Italy PubMed articlesGoogle scholar articles
  • Benedetta Conte Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, Genova, Italy PubMed articlesGoogle scholar articles
  • Samuel Martel Department of Hemato-Oncology, CISSS Montérégie-Centre/Hôpital Charles-Le Moyne, centre affilié de l’Université de Sherbrooke, Quebec, Canada PubMed articlesGoogle scholar articles
  • Christian Maurer Department I of Internal Medicine, Center of Integrated Oncology Cologne Bonn, University of Cologne, Cologne, Germany PubMed articlesGoogle scholar articles
  • Marco Tagliamento Department of Medical Oncology, Oncologia Medica 2, Ospedale Policlinico San Martino, Genova, Italy PubMed articlesGoogle scholar articles
  • Giulia Viglietti Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium PubMed articlesGoogle scholar articles
  • Lucia Del Mastro Department of Medical Oncology, U.O. Sviluppo Terapie Innovative, Ospedale Policlinico San Martino, Department of Internal Medicine and Medical Specialties (DIMI), University of Genova, Genova, Italy PubMed articlesGoogle scholar articles
  • Evandro de Azambuja Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium PubMed articlesGoogle scholar articles
  • Matteo Lambertini Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium Breast Cancer Translational Research Laboratory, Institute Jules Bordet, Université Libre de Bruxelles (U.L.B.), Bruxelles, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Matteo Lambertini; matteo.lambertini85{at}gmail.com
View Full Text

Citation

Poggio F, Bruzzone M, Ceppi M, et al
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis

Publication history

  • Received March 20, 2018
  • Accepted March 29, 2018
  • First published June 20, 2018.
Online issue publication 
June 20, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.